United States · FDA National Drug Code directory
Anastrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-004_4ad5b64f-c4f3-4aa0-e063-6394a90a8a21
- Product NDC
- 76420-004
- Form
- TABLET
- Composition / generic term
- Anastrozole
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100622
- Source listing expiry
- 20271231
Source-listed ingredients
- ANASTROZOLE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE, PLASTIC (76420-004-12) · 76420-004-12
- 150 TABLET in 1 BOTTLE, PLASTIC (76420-004-15) · 76420-004-15
- 20 TABLET in 1 BOTTLE, PLASTIC (76420-004-20) · 76420-004-20
- 30 TABLET in 1 BOTTLE, PLASTIC (76420-004-30) · 76420-004-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →